Joint Statement on the WHO-Convened COVID-19 Origins Study signed by 14 countries

The text of the following statement was released by the Governments of the United States of America, Australia, Canada, Czechia, Denmark, Estonia, Israel, Japan, Latvia, Lithuania, Norway, the Republic of Korea, Slovenia, and the United Kingdom.

 More...

U.S. halts distribution of Eli Lilly’s coronavirus antibody treatment bamlanivimab as a monotherapy

The U.S. government has halted distribution of Eli Lilly’s COVID-19 antibody treatment bamlanivimab (LY-CoV555) as a monotherapy just four months after it received FDA emergency use authorization, citing a sustained increase in variants of SARS-CoV-2 that are resistant to the monotherapy.  More...

More than 60 animals confirmed with Sars-Cov-2 infection

Of the more than 60 animals confirmed with SARS-CoV-2 infection in a study of more than 450 animals living in the Brazos County area Texas A&M study, less than a quarter were reported to show signs of disease around the time of the owner’s diagnosis, most commonly including sneezing, coughing, diarrhea, or being less active than normal.  More...

Progesterone therapy may improve coronavirus outcomes for men

Clinical Trial at Cedars-Sinai Suggests Injections of Female Hormone May Reduce Disease Severity in Certain Male Patients

COVID-19 disproportionately affects men compared with women, raising the possibility that a hormone like progesterone may improve clinical outcomes for certain hospitalized men with the disease.  More...